Results 71 to 80 of about 272 (113)

Mechanisms and advantages of natural derived small molecule compounds in the prevention and treatment of colorectal cancer: a review. [PDF]

Front Pharmacol
Liao MJ, Dong HY, Chen G, Li WW, Li GF.
europepmc   +1 more source

Gut microbiome and Mediterranean diet in the context of obesity. Current knowledge, perspectives and potential therapeutic targets. [PDF]

Metabol Open, 2021
Tsigalou C, Paraschaki A, Karvelas A, Kantartzi K, Gagali K, Tsairidis D, Bezirtzoglou E.   +6 more
europepmc   +1 more source

Advances in the study of gut microecology and mechanisms of hyperuricemia and gouty arthritis. [PDF]

Front Immunol
Zhang Y, Zhang H, Miao T, Wang X, Zuo Y, Zhang R, Zhang L, Cheng Y, Liu D, Chen X, Li L, Xie X, Li N.   +12 more
europepmc   +1 more source

An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota. [PDF]

Viruses, 2022
Li S, Zhou Y, Yan D, Wan Y.
europepmc   +1 more source

Microbiome dysbiosis in SARS-CoV-2 infection: implication for pathophysiology and management strategies of COVID-19. [PDF]

Front Cell Infect Microbiol
Smail SW, Albarzinji N, Salih RH, Taha KO, Hirmiz SM, Ismael HM, Noori MF, Azeez SS, Janson C.   +8 more
europepmc   +1 more source

Multi-kingdom microbial changes and their associations with the clinical characteristics in schizophrenia patients. [PDF]

Transl Psychiatry
Zhu B, Liang L, Chen S, Li H, Huang Y, Wang W, Zhang H, Zhou J, Xiong D, Li X, Li J, Ning Y, Shi X, Wu F, Wu K.   +14 more
europepmc   +1 more source

Impact of a Moderately Hypocaloric Mediterranean Diet on the Gut Microbiota Composition of Italian Obese Patients. [PDF]

Nutrients, 2020
Pisanu S, Palmas V, Madau V, Casula E, Deledda A, Cusano R, Uva P, Vascellari S, Boi F, Loviselli A, Manzin A, Velluzzi F.   +11 more
europepmc   +1 more source

Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics. [PDF]

Front Cell Infect Microbiol
Orejudo M, Gómez MJ, Riestra S, Rivero M, Gutiérrez A, Rodríguez-Lago I, Fernández-Salazar L, Ceballos D, Benítez JM, Aguas M, Bastón-Rey I, Bermejo F, Casanova MJ, Lorente-Poyatos RH, Ber Y, Ginard D, Esteve M, de Francisco R, García MJ, Francés R, Rodríguez A, Alcaide Suárez N, Guerra Del Río E, Soto P, Nos P, Barreiro-de Acosta M, Guerra I, Hervías Cruz D, Domínguez Cajal M, Royo V, Aceituno M, Aldars-García L, Garre A, Ramírez C, Soleto I, Schuppe-Koistinen I, Engstrand L, Baldán-Martín M, Sánchez-Cabo F, Gisbert JP, Chaparro M.   +40 more
europepmc   +1 more source

Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model. [PDF]

ACS Pharmacol Transl Sci
Sharma S, Gilberto VS, Levens CL, Chatterjee A, Kuhn KA, Nagpal P.   +5 more
europepmc   +1 more source

Gut microbiota and viral respiratory infections: microbial alterations, immune modulation, and impact on disease severity: a narrative review. [PDF]

Front Microbiol
El-Khoury G, Hajjar C, Geitani R, Karam Sarkis D, Butel MJ, Barbut F, Abifadel M, Kapel N.   +7 more
europepmc   +1 more source